Glucagon-like peptide-1 (GLP-1) receptor agonist drugs, like the popular weight-loss jabs Wegovy and Ozempic, have proven to be immensely effective
The STEP 1 trial, published in the New England Journal of Medicine in 2021, showed that participants taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
How do you decide which medication is best for me
Current knowledge on exosome biogenesis and release
GHK-Cu: copper transport, ECM remodeling, redox modulation GHK-Cu is a coordination complex between the tripeptide Gly-His-Lys and Cu(II), first isolated from human plasma by Loren Pickart in 1973
For example, in the study we cited where berberine went up against metformin, 35% of subjects had significant gastrointestinal upset when taking the 1,500 mg/day dose (three capsules worth)